Project Grant R44DK107114

Persista Bio Inc. received a $3.28 million Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) awarded on September 8, 2025. The grant funds advanced preclinical development of the O2LINE System, a safe, anti-fibrotic, oxygenated cell encapsulation device designed to enable Type 1 Diabetes (T1D) cell replacement therapy without the need for immunosuppression....

Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded Intailor Bariatrics, LLC a Project Grant of $325,408 under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) on September 8, 2025, with a completion date of August 31, 2026. The grant supports development and advancement of an automated endoscopic gastroplasty device designed to provide a minimally invasive alternative to traditional bariatric...

The federal Project Grant award R43DK137616 for $275,766.00 was provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award funds Biosurfaces Inc., a for-profit medical device company, to develop and evaluate an implantable, electrospun cell chamber device loaded with human pancreatic islets. The device aims to provide an immune-protected environment to support...

This National Science Foundation (NSF) Division of Computer and Network Systems Project Grant award totaling $839,998 to Michigan State University supports the development of a novel wireless optoelectronic implant system for closed-loop control of bi-hormone (insulin and glucagon) secretion from genetically modified islet organoids. The goal is to create an implantable, wireless, and battery-free device that can precisely regulate hormone levels to manage type 1 diabetes. The project involves...

Grant Award Summary Vanderbilt University Medical Center received a $177,986 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective September 9, 2025, with a completion date of July 31, 2030. The award funds a pilot, Phase II clinical trial investigating the use of tirzepatide (TRZ), a glucagon-like peptide-1 receptor agonist, as an adjuvant...

Federal Grant Award Summary Persista Bio Inc. received $287,250 in Project Grant funding from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to develop and manufacture clinical-grade cell capsules for the O2LINE implant system, an advanced oxygenated cell encapsulation technology for Type 1 Diabetes (T1D) treatment. The award, granted on September 11, 2025, with completion...

Federal Grant Award Summary The Jaeb Center for Health Research Foundation, Inc. received a $2.34 million Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), awarded September 3, 2025, with completion scheduled for August 31, 2028. The project, titled "Care Partner-Assisted Implementation of Patch Hybrid Closed Loop Insulin Delivery for Older Adults...

Federal Grant Award Summary Integrated Medical Sensors Inc. received a $275,275 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) on September 17, 2025, with a completion date of August 31, 2026. The award supports the development and optimization of "GlucoSoft," a miniaturized and flexible continuous glucose monitoring (CGM) platform designed to...

Federal Grant Award Summary Integrated Medical Sensors Inc. received a $569,998 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective September 1, 2025, through July 31, 2026. The award funds the development and validation of optimized data processing algorithms for real-time glucose monitoring on a multi-sensor integrated platform. Specifically,...

Federal Cooperative Agreement Summary The University of California, San Diego received a $2.26 million Cooperative Agreement award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective September 11, 2025, with completion scheduled for August 31, 2028. The award funds a clinical research initiative to evaluate the safe use of sodium-glucose cotransporter inhibitors...